Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Chenyang Li, Chujun Cai, Chendong Wang, Xiaoping Chen, Bixiang Zhang, Zhao Huang

Clin Mol Hepatol. 2025;31(2):350-381. Published online December 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0857

View: 1719 Download: 224

Satya Priya Sharma, Ki Tae Suk

Clin Mol Hepatol. 2025;31(1):e74-e77. Published online October 15, 2024

DOI: https://doi.org/10.3350/cmh.2024.0872

View: 1170 Download: 48

Soon Kyu Lee, Jong Young Choi

Clin Mol Hepatol. 2025;31(1):301-303. Published online August 30, 2024

DOI: https://doi.org/10.3350/cmh.2024.0716

View: 1015 Download: 72 Crossref: 1

Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen

Received December 2, 2024 Accepted February 4, 2025

DOI: https://doi.org/10.3350/cmh.2024.1090 [Accepted]

View: 476 Download: 76

1 |

Viewed By 9025	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7697	MAFLD: How is it different from NAFLD?
Viewed By 5561	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5163	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4617	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 293	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 204	MAFLD: How is it different from NAFLD?
Cited By 103	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes

Search